5 completed, 3 recruiting, 1 not yet recruiting, 1 unknown. 10 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 5, Recruiting 3, Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Teniposide: new trials by email Literature Review of Teniposide trials Research Report on Teniposide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL Teniposide, Orelabrutinib, MTX - Primary Central Nervous System Lymphoma | Phase 2 / Phase 3 | Recruiting | Huashan Hospital | 215 | 2025-10-01 | 2026-08-19 |
| Study of Precision Treatment for Rare Tumours in China Guided by PDO and NGS Albumin-Bound Paclitaxel, Epirubicin, Gemcitabine - Rare Tumour | Phase 2 | Not yet recruiting | Peking University Shenzhen Hospital | 200 | 2025-01-01 | 2024-11-18 |
| Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin. Teniposide Injection - GCT, Germ Cell Tumor | Phase 2 | Recruiting | Chengcheng Guo | 40 | 2024-08-13 | 2025-09-23 |
| Teniposide, Cisplatin and Serplulimab for Treatment of ES-SCLC, a Randomized Controlled Study Teniposide, Etoposide, serplulimab - Small-cell Lung Cancer | Phase 2 | Recruiting | Sun Yat-sen University | 90 | 2024-02-01 | 2026-05-13 |
| Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma dexamethasone, vincristine sulfate, rituximab - Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma | Phase 2 | Completed | St. Jude Children's Research Hospital | 80 | 2013-04-15 | 2022-09-28 |
| Intensified Post Remission Therapy Containing PEG-Asparaginase Daunorubicin, Vincristine, Prednisone, Methotrexate, PEG-Asparaginase, 6-Mercaptopurine, Cytoxan, Cytosine Arabinoside, VM-26 and 6-Thioguanine - Acute Lymphoblastic Leukemia | Phase 2 | Completed | University of Southern California | 47 | 2004-07-01 | 2014-05-22 |
| Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia Etoposide, cytarabine, vincristine, dexamethasone, methotrexate, teniposide, PEG-asparaginase, mitoxantrone, cyclophosphamide, mercaptopurine, vinblastine - Acute Lymphoblastic Leukemia, Lymphoma, Lymphoblastic | Phase 2 | Completed | St. Jude Children's Research Hospital | 47 | 2003-11-01 | 2017-07-28 |
| Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma aldesleukin, filgrastim, recombinant interferon alfa - Lymphoma | Phase 2 | Completed | Northwestern University | 1999-10-01 | 2012-06-06 | |
| Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma ifosfamide, paclitaxel, teniposide - Lymphoma | Phase 1 / Phase 2 | Completed | Northwestern University | 1999-02-01 | 2012-06-06 | |
| Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia asparaginase, cyclophosphamide, cytarabine - Leukemia | Phase 2 | Unknown | Johann Wolfgang Goethe University Hospital | 1993-01-01 | 2013-09-17 |
Lymphoma (4) · Leukemia (3) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Burkitt Lymphoma (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms, Germ Cell and Embryonal (1) · Small Cell Lung Carcinoma (1)
Northwestern University (2) · St. Jude Children's Research Hospital (2) · Chengcheng Guo (1) · Huashan Hospital (1) · Johann Wolfgang Goethe University Hospital (1) · Peking University Shenzhen Hospital (1) · Sun Yat-sen University (1) · University of Southern California (1)
United States (5) · China (3) · Germany (1)
Leo I. Gordon, MD (2) · Sima Jeha, MD (2) · Dan Douer, MD (1) · Dieter Hoelzer, MD, PhD (1) · Tong Chen (1) · Wenfeng Fang (1)